Full Coverage

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment...

                   
redorbit.com
Nov 4, 2009
 
Story Timeline:  23 days

Posted on: Wednesday, 4 November 2009, 04:00 CST SAN DIEGO, Nov. 4 /PRNewswire/ -- NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment... [read full story]                    

powered by
Add Comment
Latest article on this story:

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment...

 comparenetworks.com Nov 5, 2009
First article on this story:

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment...

 prnewswire.com Nov 4, 2009
Selected publications with coverage of this story:
redorbit.com news-medical.net prnewswire.com bio-medicine.org earthtimes.org mediconews.com comparenetworks.com
RELATED
Found 6 documents:
                   

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment...

comparenetworks.com
Nov 5, 2009
 

NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix® Phase III clinical trial in patients...

powered by
                   

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment...

bio-medicine.org
Nov 4, 2009
 

SAN DIEGO, Nov. 4 /- NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix® Phase III...

powered by
                   

FDA approves SPA Protocol Amendment for Lucanix Phase III clinical trial

mediconews.com
Nov 4, 2009
 

FDA approves SPA Protocol Amendment for Lucanix Phase III clinical trial NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol...

powered by
                   

FDA approves SPA Protocol Amendment for Lucanix Phase III clinical trial

news-medical.net
Nov 4, 2009
 

NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix® Phase III clinical trial in patients...

powered by
                   

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment...

earthtimes.org
Nov 4, 2009
 

SAN DIEGO, Nov. 4 /PRNewswire/ -- NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix®...

powered by
                   

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment...

prnewswire.com
Nov 4, 2009
 

SAN DIEGO, Nov. 4 /PRNewswire/ -- NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix®...

powered by